Indraprastha Medical Corporation Ltd (INDRAMEDCO) — Board Meeting | 1 September 2026
The filing confirms the 38th AGM of Indraprastha Medical Corporation Ltd on 24 September 2026, where shareholders will adopt FY25-26 financials, declare a ₹4 per share dividend (40% on ₹10 face value), and reappoint directors. Key resolutions include ratifying cost auditor remuneration and updating shareholder records. The company maintains a ₹3,413.44 crore market cap, ₹36.67 crore dividend payout, and ₹991.36 crore total assets. Governance updates include new independent directors (Sudhir Jalan, Harsh Pati Singhania, Vineeta Rai, Salil Singhal) and board restructuring. ESG disclosures highlight ₹326 lakh CSR spend, 10% energy reduction targets, and 84% patient satisfaction goals. No material litigation risks were identified beyond a pending Supreme Court case on free treatment policies.
About Indraprastha Medical Corporation Ltd (INDRAMEDCO)
Healthcare · Healthcare · Listed on BSE
📡 Get AI alerts when INDRAMEDCO files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track INDRAMEDCO — Free💡 Ask AI about this filing
📊 More INDRAMEDCO filings
- 🟡 Board Meeting — 29 August 2026 Indraprastha Medical Corporation announced its 38th AGM will be held on 24 September 2026 via video ...
- share transfer — 9 July 2026 Indraprastha Medical Corporation Limited received a SEBI-mandated share transfer agent certificate f...
- Financial Results — 24 June 2026 Indraprastha Medical Corporation Limited announced that its trading window will close on 1 July 2026...
- 🔴 Announcement — 19 June 2026 No summary available
- Announcement — 2 June 2026 Indraprastha Medical Corporation Limited announced its upcoming investor and analyst meetings schedu...
🔥 Also filed on 1 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when INDRAMEDCO files new disclosures
Track INDRAMEDCO filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track INDRAMEDCO — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd